A Phase 3 Study of Pacritinib in Patients With Primary Myelofibrosis, Post Polycythemia Vera Myelofibrosis, or Post-Essential Thrombocythemia Myelofibrosis
Clinical trial NCT03165734 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT03165734
- Sponsor
- Swedish Orphan Biovitrum
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2017-06-26
- Primary completion
- 2026-10-05
- Enrollment
- 407
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.